Cheap Anti-depressant Shows Promise Treating Early COVID
The $4 pill reduced the need for hospitalization among high-risk adults
A cheap anti-depressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
They've shared the results with the U.S. National Institutes of Health (NIH), which publishes treatment guidelines, and they hope for a World Health Organization (WHO) recommendation.
Please select this link to read the complete article from NBC News.